Cigna Group announced impressive Q1 2026 results, with net income reaching $1.65 billion and an adjusted EPS of $7.79, largely driven by its Evernorth unit's performance. The company's robust revenue growth has prompted an increase in its FY26 adjusted EPS forecast to at least $30.35. However, despite these positive developments, Cigna's stock saw a decline recently, reflecting broader market fluctuations, yet it maintains a significant market cap of approximately $75.46 billion, indicating resilient investor confidence.